241 related articles for article (PubMed ID: 3838794)
1. Parathyroid function and vitamin D status in patients with bone metastases of prostatic origin.
Charhon SA; Chapuy MC; Delvin EE; Meunier PJ
Miner Electrolyte Metab; 1985; 11(2):117-22. PubMed ID: 3838794
[TBL] [Abstract][Full Text] [Related]
2. Alterations in vitamin D metabolites during treatment of Paget's disease of bone with calcitonin or etidronate.
Devlin RD; Gutteridge DH; Prince RL; Retallack RW; Worth GK
J Bone Miner Res; 1990 Nov; 5(11):1121-6. PubMed ID: 2125401
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D metabolites and calcium absorption in severe vitamin D deficiency.
Need AG; O'Loughlin PD; Morris HA; Coates PS; Horowitz M; Nordin BE
J Bone Miner Res; 2008 Nov; 23(11):1859-63. PubMed ID: 18597633
[TBL] [Abstract][Full Text] [Related]
4. Chronic adaptation of dog parathyroid function to a low-calcium-high-sodium-vitamin D-deficient diet.
Cloutier M; Gascon-Barré M; D'Amour P
J Bone Miner Res; 1992 Sep; 7(9):1021-8. PubMed ID: 1414494
[TBL] [Abstract][Full Text] [Related]
5. The effects of high-dose glucocorticoid administration on serum bone gamma carboxyglutamic acid-containing protein, serum alkaline phosphatase and vitamin D metabolites in normal subjects.
Nielsen HK; Thomsen K; Eriksen EF; Charles P; Storm T; Mosekilde L
Bone Miner; 1988 Apr; 4(1):105-13. PubMed ID: 3263890
[TBL] [Abstract][Full Text] [Related]
6. Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols.
Salusky IB; Goodman WG; Sahney S; Gales B; Perilloux A; Wang HJ; Elashoff RM; Jüppner H
J Am Soc Nephrol; 2005 Aug; 16(8):2501-8. PubMed ID: 15944337
[TBL] [Abstract][Full Text] [Related]
7. A study of calcium and vitamin D metabolism in Chinese patients with pulmonary tuberculosis.
Chan TY; Poon P; Pang J; Swaminathan R; Chan CH; Nisar M; Williams CS; Davies PD
J Trop Med Hyg; 1994 Feb; 97(1):26-30. PubMed ID: 8107170
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of prostate-specific antigen and vitamin D in peritoneal dialysis patients.
Passadakis P; Ersoy F; Tam P; Memmos D; Siamopoulos K; Ozener C; Akçiçek F; Camsari T; Ates K; Ataman R; Vlachojannis J; Dombros N; Utas C; Akpolat T; Bozfakioglu S; Wu GG; Karayaylali I; Arinsoy T; Stathakis C; Yavuz M; Tsakiris D; Dimitriades A; Yilmaz ME; Gültekin M; Karayalçin B; Challa A; Polat N; Oreopoulos DG
Adv Perit Dial; 2004; 20():203-8. PubMed ID: 15384827
[TBL] [Abstract][Full Text] [Related]
9. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
Lee SH; Huang TS; Hsieh SJ
Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid function in Paget's disease of bone.
Siris ES; Clemens TP; McMahon D; Gordon A; Jacobs TP; Canfield RE
J Bone Miner Res; 1989 Feb; 4(1):75-9. PubMed ID: 2718781
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid function in primary osteoporosis.
Riggs BL; Arnaud CD; Jowsey J; Goldsmith RS; Kelly PJ
J Clin Invest; 1973 Jan; 52(1):181-4. PubMed ID: 4734167
[TBL] [Abstract][Full Text] [Related]
12. Effect of aminohydroxypropylidene diphosphonate on the bone metabolism of patients with parathyroid adenoma.
Ishimura E; Miki T; Koyama H; Harada K; Nakatsuka K; Inaba M; Nishizawa Y; Morii H
Horm Metab Res; 1993 Sep; 25(9):493-7. PubMed ID: 8225204
[TBL] [Abstract][Full Text] [Related]
13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
14. Secondary hyperparathyroidism in primary osteoporosis and osteopenia: optimizing calcium and vitamin D intakes to levels recommended by expert panels may not be sufficient for correction.
Yendt ER; Kovacs KA; Jones G
Clin Endocrinol (Oxf); 2008 Dec; 69(6):855-63. PubMed ID: 18419790
[TBL] [Abstract][Full Text] [Related]
15. Effect of phenytoin on bone and vitamin D metabolism.
Bell RD; Pak CY; Zerwekh J; Barilla DE; Vasko M
Ann Neurol; 1979 Apr; 5(4):374-8. PubMed ID: 220903
[TBL] [Abstract][Full Text] [Related]
16. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D physiology.
Lips P
Prog Biophys Mol Biol; 2006 Sep; 92(1):4-8. PubMed ID: 16563471
[TBL] [Abstract][Full Text] [Related]
18. [Effects of weightlessness on phospho-calcium metabolism and its hormonal regulation in man during the 51 G Franco-American space flight].
Alexandre C; Vico L; Pilonchery G; Chapuy MC; Delmas PD; Chappard D
Pathol Biol (Paris); 1988 Feb; 36(2):144-8. PubMed ID: 3279382
[TBL] [Abstract][Full Text] [Related]
19. [Serum concentrations of 1,25-dihydroxyvitamin D in cases of osteomalacia, parathyroid dysfunction and idiopathic hypercalciuria].
Audran M; Renier JC; Jallet P; Bidet M; Basle MF; Seret P
Rev Rhum Mal Osteoartic; 1987 Feb; 54(2):163-9. PubMed ID: 3563383
[TBL] [Abstract][Full Text] [Related]
20. [Review of the concept of vitamin D "sufficiency and insufficiency"].
Gómez Alonso C; Naves Díaz M; Rodríguez García M; Fernández Martín JL; Cannata Andía JB
Nefrologia; 2003; 23 Suppl 2():73-7. PubMed ID: 12778859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]